Denali Capital extends business combination deadline to Feb 11, 2025; deposits $15k via Scilex note

Semnur Pharmaceuticals, Inc.

Deposited $15,063.74 into trust account to extend deadline from Jan 11 to Feb 11, 2025.
Extension funded via convertible promissory note from Scilex Holding Company (SCLX) with principal up to $180,000.
Note bears no interest, repayable upon business combination or liquidation; convertible at $10.00/share.
Remaining $89,672.56 available under note to fund potential future one-month extensions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.